SPDR S&P Pharmaceuticals ETF
$42.99
(0.66%) 0.28 at
2024-12-31 16:00:00
(0.66%) ($0.28) at 2024-12-31 16:00:00
1M
6M
1Y
5Y
MAX
52-week lows/highs
$42.99
$38.88
$48.76
52-week low
52-week high
Top 10 holdings
+46
ETF AUM
$158.26M
as of 2024-12-31 16:00:00
Expense ETF ratio
0.35%
as of 2024-12-31 16:00:00
Dividend yield of the ETF
-
as of 2024-12-31 16:00:00
NAV
43.04
ETF Company
SPDR
Investment Segment
Health Care
PriceToBook
2.93
Allocations
Health Care
99.74%
Other
0.26%
View all
United States
98.92045%
Singapore
1.07955%
View all
ESG score (%)
0
Prime
Compared with 30,211 companies
Minor
0-29
Low
30-39
Mid
40-49
Steady
50-59
High
60-79
Prime
80-100
View screening report
About the ETF
XPH was created on 2006-06-19 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 156.54m in AUM and 46 holdings. XPH tracks an equal-weighted index of US pharmaceutical companies.
SPDR S&P Pharmaceuticals
